160 related articles for article (PubMed ID: 36583803)
1. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
Wang H; Chen W; Qi Y; Liu D; Liu Z; Zhang Q; Yi Y; Wang J; Wu W
Dig Dis Sci; 2023 May; 68(5):1923-1935. PubMed ID: 36583803
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma.
Che J; Su Z; Yang W; Xu L; Li Y; Wang H; Zhou W
Dig Liver Dis; 2023 Mar; 55(3):412-421. PubMed ID: 35853821
[TBL] [Abstract][Full Text] [Related]
3. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
4. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
[TBL] [Abstract][Full Text] [Related]
6. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
7. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
8. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
Shi Y; Yan F; Wang F; Pan L
Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
[TBL] [Abstract][Full Text] [Related]
9. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
11. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
Zhang L; Zhao Y; Guan H; Zhang D
Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
[TBL] [Abstract][Full Text] [Related]
13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
14. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
[TBL] [Abstract][Full Text] [Related]
16. TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway.
Zhu D; Xu X; Zhang M; Wang T
Oncol Lett; 2022 May; 23(5):143. PubMed ID: 35340555
[TBL] [Abstract][Full Text] [Related]
17. lncRNA TUG1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma via Regulating miR-29c-3p/
Zhao W; Jiang X; Yang S
Cancer Manag Res; 2020; 12():6837-6847. PubMed ID: 32821161
[TBL] [Abstract][Full Text] [Related]
18. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
19. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
Huang Y; Guo W; Kan H
Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
